Parkinson's UK

Introduction

Overview

Parkinson’s UK is the leading UK charity for Parkinson’s research and support. Founded in 1969 as the Parkinson’s Disease Society, the organization has invested over £85 million in research to find better treatments and ultimately a cure for Parkinson’s disease^{1Parkinson's UK Annual ReportOpen reference}. The charity supports people living with Parkinson’s across the UK through a network of local branches, specialist nurses, and information resources.

Parkinson’s UK plays a crucial role in the Parkinson’s research ecosystem, funding cutting-edge research into the understanding of Parkinson’s, development of new treatments, and clinical trials. The organization also advocates for people with Parkinson’s and their families, working to improve care and services nationwide.

Research Programs

Priority Research Areas

• Understanding Parkinson’s: Funding research into the causes and mechanisms of Parkinson’s

• Drug Development: Supporting the development of new treatments and therapies

• Clinical Trials: Funding and facilitating clinical trials for new treatments

• Care and Quality of Life: Research into improving daily living for people with Parkinson’s

Major Research Initiatives

Parkinson’s UK Research Network

A nationwide network of research centers and experts collaborating on Parkinson’s research. The network includes:

• Leading university research departments

• NHS hospital trusts

• Specialist Parkinson’s centers

Drug Discovery Pipeline

Parkinson’s UK funds a portfolio of drug discovery projects

For more information about the Drug Club repurposing program, see Parkinson’s UK Drug Club.

For an overview of all major PD drug repurposing consortia, see Parkinson’s Disease Drug Repurposing Consortia. targeting:

• Alpha-synuclein - the protein that forms Lewy bodies

• LRRK2 - a common genetic cause of Parkinson’s

• GBA gene - one of the most significant genetic risk factors

• Neuroprotection - protecting dopamine-producing neurons

• Mitochondrial function - energy production in cells

• Neuroinflammation brain inflammation in Parkinson’s

Partnership Funding

The charity partners with:

• Michael J. Fox Foundation - Joint research initiatives

• Cure Parkinson’s - Combined funding for clinical trials

• Parkinson’s Foundation - International collaboration

• Medical Research Council (MRC)

• Wellcome Trust

Support Services

Parkinson’s Nurses

The charity funds specialist Parkinson’s nurses who provide:

• Clinical expertise and medication management

• Emotional support and counseling

• Care coordination

• Education for patients and families

Local Branches

Over 300 local branches across the UK provide:

• Peer support groups

• Social activities

• Information and resources

• Fundraising events

Information and Resources

• Parkinson’s UK Information Centre - Free, confidential information

• Fact sheets and guides - Comprehensive disease information

• Webinars and podcasts - Expert-led educational content

• ** publications** - Research updates and magazine

Advocacy and Campaigning

Parkinson’s UK advocates for:

• Increased research funding

• Better access to treatments and therapies

• Improved healthcare services

• Employment support for people with Parkinson’s

• Disability rights and benefits

“Parkinson’s Is” Campaign

A public awareness campaign highlighting the diverse impact of Parkinson’s beyond motor symptoms.

History

• 1969: Founded as the Parkinson’s Disease Society

• 1990s: Expanded support services nationwide

• 2000: Launched major research funding program

• 2010: Renamed to Parkinson’s UK

• 2015: Reached £75 million in research investment

• 2020: Launched new 5-year research strategy

• 2023: Over 300 local branches serving communities

Research Achievements

Key Funded Research

• Identification of new genetic risk factors for Parkinson’s

• Development of alpha-synuclein biomarkers

• Clinical trials of repurposed drugs (exenatide, inosine, etc.)

• Understanding of gut-brain connection in Parkinson’s

• Development of novel drug delivery methods

Notable Collaborations

• International Parkinson’s Genetics Project

• Global Parkinson’s Genetics Program (GP2)

• European Parkinson’s Disease Association

Impact and Outcomes

Research Impact Metrics

Parkinson’s UK research investment has yielded significant scientific outcomes:

• Publication Impact: Funded research has resulted in over 500 peer-reviewed publications in high-impact journals

• Clinical Translation: Several funded projects have advanced to clinical trials, including the landmark exenatide trial for Parkinson’s disease

• Training: The charity has supported over 200 PhD students and postdoctoral researchers, building the next generation of Parkinson’s researchers

Patient-Centered Outcomes

The organization’s work has directly improved quality of life for people with Parkinson’s:

• Specialist nurse provision expanded to over 100 NHS trusts

• Information resources distributed to over 50,000 individuals annually

• Local support network expanded to more than 300 branches

• Campaigning efforts led to increased NHS funding for Parkinson’s services

Funding and Financials

Research Investment

Parkinson’s UK maintains substantial research expenditure:

• Annual research budget of approximately £8-10 million

• Portfolio of 40-50 active research grants at any time

• Average grant duration of 3-5 years

• Focus on translational research with clinical impact potential

Funding Sources

• Individual donations and legacies

• Corporate partnerships

• Trust and foundation grants

• Community fundraising events

• Investment returns on endowment

Current Strategic Priorities 2024-2028

Research Focus Areas

The current research strategy emphasizes:

1. Disease Modification: Finding treatments that slow or stop Parkinson’s progression

2. Personalized Medicine: Developing biomarker-guided treatment approaches

3. Early Detection: Supporting research into prodromal diagnosis

4. Better Treatments: Funding development of improved symptomatic therapies

Organizational Goals

• Raise £100 million for research by 2028

• Double the number of clinical trials in the UK

• Expand international collaboration networks

• Increase research capacity through training programs

Governance and Leadership

Board Structure

Parkinson’s UK is governed by a board of trustees with expertise in:

• Neuroscience and medical research

• Healthcare management

• Finance and business

• Patient advocacy

Scientific Advisory Board

An expert scientific advisory board reviews research funding decisions, ensuring:

• Rigorous peer review of grant applications

• Alignment with latest scientific advances

• Focus on highest-impact research questions

Volunteer and Community Engagement

Volunteer Programs

The organization engages thousands of volunteers:

• Research ambassadors who engage communities in research

• Peer support volunteers at local branches

• Fundraising volunteers organizing events

• Campaign advocates pushing for policy change

Patient Involvement

Parkinson’s UK incorporates patient voices in research:

• Patient representatives on research funding panels

• PPI (Patient and Public Involvement) in study design

• Patient advisory groups shaping research priorities

Future Directions

Emerging Research Areas

Current frontier research includes:

• Alpha-Synuclein Spread: Understanding prion-like propagation of alpha-synuclein pathology

• Microbiome Research: Investigating gut-brain axis in Parkinson’s pathogenesis

• Genetic Discovery: Continuing genome-wide association studies in diverse populations

• Neuroprotection: Development of disease-modifying neuroprotective agents

Technology and Innovation

The charity supports innovative approaches:

• Digital health solutions for symptom monitoring

• AI and machine learning for biomarker discovery

• Advanced neuroimaging techniques

• Wearable technology for gait and tremor analysis

See Also

• Alzheimer’s Disease

• Parkinson’s Disease

• Michael J. Fox Foundation

• Cure Parkinson’s

• Parkinson’s Foundation

External Links

• Parkinson’s UK Official Website

• Research Strategy

• Annual Reports